PashtoonMurtazaKasiMD

Cancer Genetics/Cancer Risk Assessment, Gastrointestinal Cancer, Hematologic Oncology

Oncology, Gastrointestinal Malignancies (Colon & Rectal Cancer; Hereditary GI Cancers, BRCA 1/2)

Dr. Kasi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Associate Professor Oncology,
Post-Doctoral Master’s in Basic and Biomedical Sciences.

Immunotherapy, Biological Therapy, Medical oncology, Hematology, Toll-Like Receptor 4, Tumor Cell Line, Combined modality therapy, Adjuvant chemotherapy, Gastrointestinal / Hepatic pathology, Colonic neoplasms, Cholangiocarcinoma, Pancreatic Neoplasms, BRCA2 Genes, BRCA1 Genes, Gastrointestinal oncology, Hematologic oncology, Colon cancer, Liver metastases, Metastatic diseases, Hepatic metastases, Metastatic colon cancer, Colorectal cancer, Hereditary nonpolyposis colorectal cancer, General medical oncology, Pancreatic cancer, Hepatic cancer

Mayo School of Graduate Medical EducationM.S., Basic and Biomedical Sciences , 2015 - 2018
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2013 - 2016
UPMC Medical EducationResidency, Internal Medicine, 2010 - 2013
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Transitional Year, 2009 - 2010
Aga Khan Medical CollegeClass of 2006

PubMed

Journal Articles

Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
Pashtoon M Kasi, Robert R McWilliams, JAMA

Lectures

A phase II trial of pharmacological ascorbate, gemcitabine, and nabpaclitaxel for metastatic pancreatic cancer.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
and microsatellite instability prediction through CA-19-9/CEA ratio in patients with colorectal cancer.
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
Circulating tumor DNA dynamics, serial testing and evolution on treatment in 322 colorectal cancer patients.
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
Incidence of pathogenic variants in individuals with a personal or family history of pancreatic cancer.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Join now to see all

Randy Moss' Rare GI Cancer: Here's What to KnowDecember 20th, 2024
Active Surveillance or Maintenance After Chemo Induction in Metastatic CRC?March 8th, 2022
Detecting Cancer with a Simple Blood Draw Could Soon Be a RealityNovember 24th, 2021
Join now to see all

Colon Cancer - Career Development AwardNorma Lee and Morton Funger Clinician Career 2017 Development Fund Award in Colon Cancer Research ($150,000) for establishment and molecular characterization of a patient-derived colorectal cancer tissue2017–2020
BRCA-Related Pancreatic Cancer: Outcomes and PD-L1 expressionMayo Clinic Cancer Center2017–2019